2020-04-22 - Cancer Synoptic Reporting Project Group Meeting
Cancer Synoptic Reporting Project Group
Date
22nd, April 2020 at 16:00 UTC
Attendees
@Scott Campbell @Ian Green @Jim Case @Monica Harry @Suzanne Santamaria @Farzaneh Ashrafi @Jim Campbell @Daniel Karlsson @Former user (Deleted) @Paul @Keng-Ling Wallin @Former user (Deleted) @Former user (Deleted) @Emma Melhuish @Former user (Deleted) stefan dubois @VScoutellas
Apologies
Discussion items
Item | Description | Owner | Notes | Action |
---|---|---|---|---|
1 | Objectives:
| Meeting held on 2020-04-22 and on 2020-04-29 | ||
2 | Review of existing concept modelling decisions and templates as documented by Scott and Jim Campbell | Scott/Jim Campbell | Topic addressed on 2020-04-22: Discussion concerning tumor extension. Current Nebraska model uses the attribute |Process output| to describe terminus of tumor extension. Consensus of meeting attendees is to create new attribute, |Process target|, specific to this use case to avoid overloading of attribute use. To be coordinated with Observables group. Primary topic address on 2020-04-29: Observable concepts regarding presence and extent of neoplasm at surgical margin was discussed at length. Modeling change was unanimously agreed upon: Property = |Presence| Component = <<|Morphologic abnormality| Inheres in = <<|Surgical margin (morphologic abnormality)| Inherent location = <<|Body structure| (organ/body structure of malignant neoplasm| Direct site = <<|Specimen| Scale type = Ordinal Time Aspect = Single point in time Semantic tag for Surgical margin changed and is now a subtype of 245849007 |Post-surgical anatomy (morphologic abnormality)| Other items discussed: Genomic naming conventions. For the time being, FSN will be the scientific long name with punctuation removed per editorial policy. PT will use the HGNC short term (e.g. BRAF) Additional discussion needed for genomics modeling as SI not settled on model, yet. Need to review modeling for immunohistochemistry in breast cancer. Use of |Component| attribute favored in lieu of existing |Direct site| attribute. FSN may need editing to reflect model better. Morphologic abnormalities specific to histologic types will not be added unless reviewed by Anatomy Working Group and supported by scientific literature, not necessarily what the "name of the day" is for a particular histologic change as reflected in any one society's synoptic protocols. | |
3 | Discuss and edit modeling decisions as necessary. (This will necessarily involve MRCM level discussion0 | All | @Scott Campbell to edits Inception and elaboration document for agreed upon modeling changes. | |
4 | Agree next steps | Scott Campbell | Agreed that group should begin to meet regularly now that multiple sources/parties are engaged and base modeling settled. @Scott Campbell has sent Doodle poll to attendees of this meeting for available time slots. | |
5 | Date of next meeting | TBD - possibly week of 11-May |
Meeting Files
Zoom details
Join from PC, Mac, Linux, iOS or Android:
https://snomed.zoom.us/my/cancersynoptic
Or Telephone:
Dial:
+1 669 900 6833 (US Toll)
+1 408 638 0968 (US Toll)
+1 646 876 9923 (US Toll)
+370 5214 1488 (LT Toll)
+351 308 804 188 (PT Toll)
+1 647 558 0588 (CA Toll)
+44 (0) 20 3695 0088 (GB Toll)
+31 (0) 20 241 0288 (NL Toll)
+386 1888 8788 (SI Toll)
+420 2 2888 2388 (CZ Toll)
+972 (0) 3 978 6688 (IL Toll)
+48 22 307 3488 (PL Toll)
+32 (0) 2 588 4188 (BE Toll)
+34 91 198 0188 (ES Toll)
+60 3 9212 1727 (MY Toll)
+65 3158 7288 (SG Toll)
+56 41 256 0288 (CL Toll)
+353 (0) 1 691 7488 (IE Toll)
+64 (0) 4 831 8959 (NZ Toll)
+64 (0) 9 801 1188 (NZ Toll)
+61 (0) 2 8015 2088 (AU Toll)
+372 880 1188 (EE Toll)
+356 2778 1288 (MT Toll)
+46 (0) 8 4468 2488 (SE Toll)
+41 (0) 31 528 0988 (CH Toll)
+852 5808 6088 (HK Toll)
+47 2396 0588 (NO Toll)
+421 233 056 888 (SK Toll)
+45 89 88 37 88 (DK Toll)
Meeting ID: 825 039 2968
International numbers available: https://snomed.zoom.us/zoomconference?m=zO0GQ3cmBR4JIqPdb-VsAr-EyDt3X27B
Previous Meetings
Title | Creator | Modified |
---|---|---|
No content found. |
Copyright © 2025, SNOMED International